prikaz prve stranice dokumenta N-glycosylation of complement component 3 in type 1 diabetes
  Download
PDF 3.41 MB
Conference presentation
N-glycosylation of complement component 3 in type 1 diabetes
At: 20th IDS Congress. Bruges, Belgium, 2024. urn:nbn:hr:264:851243
Šoić, Dinko; Rudman, Najda; Frkatović, Azra; Vučić-Lovrenčić, Marijana; Duvnjak, Lea; Pociot, Flemming; Gornik, Olga

Cite this document

Šoić, D., Rudman, N., Frkatović, A., Vučić Lovrenčić, M., Duvnjak, L., Pociot, F. & Gornik, O. N-glycosylation of complement component 3 in type 1 diabetes [PowerPoint slides]. Retrieved from https://urn.nsk.hr/urn:nbn:hr:264:851243

Šoić, Dinko, et al. "N-glycosylation of complement component 3 in type 1 diabetes." 20th IDS Congress, 04.11.2024.-08.11.2024., Bruges, Belgium. Presentation. https://urn.nsk.hr/urn:nbn:hr:264:851243

Šoić, Dinko, Najda Rudman, Azra Frkatović, Marijana Vučić Lovrenčić, Lea Duvnjak, Flemming Pociot and Olga Gornik. "N-glycosylation of complement component 3 in type 1 diabetes." Presentation at 20th IDS Congress, Bruges, Belgium, 04.11.2024.-08.11.2024. https://urn.nsk.hr/urn:nbn:hr:264:851243

Šoić, D., et al. 'N-glycosylation of complement component 3 in type 1 diabetes' [Presentation], 20th IDS Congress. 04.11.2024.-08.11.2024. Available at: https://urn.nsk.hr/urn:nbn:hr:264:851243

Šoić D, Rudman N, Frkatović A, Vučić Lovrenčić M, Duvnjak L, Pociot F, and sur.. N-glycosylation of complement component 3 in type 1 diabetes. [Presentation] [cited 2025 April 04] Available at: https://urn.nsk.hr/urn:nbn:hr:264:851243

D. Šoić, et al., "N-glycosylation of complement component 3 in type 1 diabetes", presented at: 20th IDS Congress, Bruges, 04.11.2024.-08.11.2024. Available at: https://urn.nsk.hr/urn:nbn:hr:264:851243

Please login to the repository to save this object to your list.
Metadata
Title (english)N-glycosylation of complement component 3 in type 1 diabetes
AuthorDinko Šoić
AuthorNajda Rudman
AuthorAzra Frkatović
AuthorMarijana Vučić-Lovrenčić
AuthorLea Duvnjak
AuthorFlemming Pociot
AuthorOlga Gornik
Author's institution(Merkur University Hospital)
Scientific / art field,
discipline and subdiscipline		BIOMEDICINE AND HEALTHCARE
Basic Medical Sciences
Medical Biochemistry
Abstract (english)
Background N-glycosylation is a modification of proteins in which oligosaccharide structures are added to protein backbones. Glycans are one of the main regulators of different immune system features and show biomarker potential in diabetes. In our work on children with type 1 diabetes (T1D), we identified a novel genetic regulator of plasma protein N-glycosylation, C3 gene. Complement component 3 (C3) is a central protein of all complement activation pathways. To study the N-glycosylation of... More C3 we developed a novel high-throughput method. Aims We analyzed C3 glycopeptides to a) compare N-glycans between children with T1D and their healthy siblings, b) search for connections between N-glycans and T1D-related complications in adults, c) define the C3 Nglycosylation in the general population and reveal its genetic regulation. Methods Glycoproteins were enriched from plasma using ConA Sepharose and digested with Glu-C. Glycopeptides were enriched with HILIC silica beads, analyzed by UPLC-MS, and quantified. C3 glycopeptides were analyzed in a) 61 children newly diagnosed with T1D and 84 unaffected siblings from DanDiabKids, b) 189 adults with T1D from Croatia, and c) 816 adults from the general Croatian population (GWAS on glycans). Results We showed that C3 has two N-glycosylation sites, with three high-mannose glycans on Asn63 and six on Asn917. Significant changes were found between children with T1D and healthy siblings, expressed through an increase in glycans with more mannose units, especially the Man9Glc. A regression model showed discriminative power with an AUC of 0.879. Significant changes were also seen in severe albuminuria, and in subjects with hypertension, but less with non-proliferative retinopathy. Glycans were associated with HbA1c levels. Smoking, eGFR, and the disease duration did not affect C3 N-glycome. We also identified 6 genome-wide significant loci associated with C3 N-glycosylation. Conclusions Our results suggest the involvement of C3 N-glycosylation in T1D development and its significant potential for assessment of T1D risk in children. It also has a value in distinguishing subjects with diabetic complications, and the potential to monitor the disease progression. Some gene variants that regulate C3 N-glycans were previously associated with different immune diseases and the activity of the complement activation pathway. Results suggest that C3 glycans could be novel targets in unraveling the pathogenesis of T1D. Less
Keywords (english)
Languageenglish
Peer reviewPeer review - international
URN:NBNurn:nbn:hr:264:851243
Presentation date2024-11
ConferenceTitle: 20th IDS Congress
Acronym: IDS
Location: Bruges, Belgium
Start date: 2024-11-04
End date: 2024-11-08
Assembly type: Poster
Type of resourceText
Access conditionsOpen access
Terms of useLicence In copyright icon
Created on2025-03-13 11:30:26
accessibility

closeAccessibilityrefresh

If you wish to permanently save changes, click on Save, if not - your settings will be reset when you restart the browser.